Announcements/Perspectives
.
Global Fund [to 5 November 2016]
http://www.theglobalfund.org/en/news/?topic=&type=NEWS;&country=
03 November 2016
Eastern European and Central Asian Countries Unite to Expand Access to Lifesaving HIV and TB Drugs
MINSK, Belarus – Health ministers from Eastern Europe and Central Asia adopted a Consensus Statement “HIV and TB treatment for all” on expanded and rapidly scaled-up access to affordable, quality-assured antiretroviral and TB drugs at the conclusion of the two-day Regional Consultation in Minsk, Belarus.
The countries committed to strengthen regional cooperation in order to advance access to affordable and quality medicines and deliver more cost-effective, equitable and sustainable solutions for common challenges by intensifying efforts through regional solidarity, shared responsibility and political leadership.
“Undoubtedly, the adoption of the Minsk Statement is a guarantee of our countries’ openness and readiness to share experience and work together in achieving sustainable development and commitments to the Political Declaration on HIV/AIDS and WHO TB Plan in Eastern Europe for 2016-2020,” said Vasiliy Zharko, Minister of Health of Belarus.
Representatives from 12 Eastern Europe and Central Asia (EECA) countries’ ministries of health – Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Federation, Tajikistan, Turkmenistan, Ukraine and Uzbekistan – endorsed the statement…
.
European Vaccine Initiative [to 5 November 2016]
http://www.euvaccine.eu/news-events
02 November 2016
Zika research supported by the European Union
The European Union launched calls to support research on emerging diseases with a substantial investment from the Horizon2020…

.
FDA [to 5 November 2016]
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
What’s New for Biologics
:: Influenza Virus Vaccine for the 2016-2017 Season
Updated: 11/2/2016
:: Study of antibody responses to an investigative Ebola vaccine may guide development and evaluation of effective countermeasures
Posted: 11/2/2016

.
PATH [to 5 November 2016]
http://www.path.org/news/index.php
Announcement | November 01, 2016
PATH announces leader for Reproductive Health Program
Martha Brady to lead PATH’s work in reproductive health
Martha Brady, MS, will join PATH as the new director of our Reproductive Health Program, beginning November 1, 2016. Based in our Washington, DC, office, she will lead our work to improve sexual and reproductive health by enhancing commitment and capacity to implement appropriate and effective interventions at scale. Her technical knowledge, experience, and track record in reproductive health will ensure continued robust and pioneering work in this area, and they will expand PATH’s work at this critical time in global health.

.
EDCTP [to 5 November 2016]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Eighth EDCTP Forum, from 6-9 November 2016 in Lusaka, Zambia.
Defeating poverty-related and neglected diseases in Africa: harnessing research for evidence-informed policies.
The symposium format allows groups of researchers or organisations to present an overview of a topic, including time for questions, discussion and exchange of views with Forum delegates.

.
Fondation Merieux [to 5 November 2016]
http://www.fondation-merieux.org/news
Mission: Contribute to global health by strengthening local capacities of developing countries to reduce the impact of infectious diseases on vulnerable populations.
4 November 2016, Les Pensières, Annecy (France)
Strategies to Increase Vaccine Acceptance and Uptake 2016
72 experts from 19 countries gathered at Les Pensières September 26-28 to discuss vaccine hesitancy and understand the drivers and barriers affecting vaccine acceptance.

.
Coalition for Epidemic Preparedness Innovations (CEPI) [to 5 November 2016]
http://cepi.net/
Newsletter 4 November 2016 [Excerpts]
:: Message from the Interim CEPI CEO
“Over the last few weeks, CEPI has participated in several meetings, including in the IMI Stakeholder meeting in Brussels, the World Health Summit in Berlin, the Global Health Security Agenda in Rotterdam, the BARDA industry days in Washington DC as well as a workshop in Berlin on preparedness for health emergencies. The CEPI message has been well received during all briefings, and feedback from a broad group of stakeholders has contributed to further guiding CEPI in achieving our mission.”
John-Arne Røttingen, Interim CEPI CEO
:: Preliminary Business Plan
The Preliminary CEPI Business Plan for the period 2017-2021 is now available on the CEPI website. The plan outlines the strategic direction for CEPI’s work, and can be found here: http://cepi.net/approach.